Author Archives: Thomas Payne

TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies

By

TScan Therapeutics to Participate in Upcoming Investor Conferences

By

TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress

By

TScan Therapeutics Announces Upcoming Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition

By

TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

By

TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

By